Stock analysis, trade plans, and proprietary indicators by Trend Edge.
About Wave Life Sciences Ltd
Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's medicines platform, PRISM combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Read full Trend Edge analysis →
Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
IPO Date: November 11, 2015
Headquarters: Marina One East Tower, Singapore, Singapore, 018936
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$6.95
Near-term / short-term trend
Weekly
40-Week SMA
$9.89
Medium-term trend
Weekly
80-Week SMA
$9.67
Cyclical trend (business cycle)
Weekly
200-Week SMA
$7.06
Secular trend (multi-year)
Monthly
10-Month SMA
$9.82
Near-term monthly trend
Monthly
20-Month SMA
$9.90
Medium-term monthly trend
Monthly
40-Month SMA
$7.51
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$13.60
resistance
1.59x
1 months ago
$17.00
resistance
1.34x
3 months ago
$5.80
support
2.26x
19 months ago
$4.90
support
2.18x
25 months ago
Historical Earnings Reactions (43 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
-0.19%
-0.15%
39.53%
5.37%
-9.61%
1 Day
-0.06%
-0.74%
41.86%
17.45%
-14.34%
1 Week
1.97%
0.72%
53.49%
42.06%
-12.97%
2 Weeks
5.19%
2.97%
60.47%
55.11%
-15.42%
1 Month
10.83%
7.08%
59.52%
134.89%
-46.30%
Next earnings: July 17, 2026 (50 days away)
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Month
Avg Return
Win Rate
Samples
Jan
-8.1%
27.3%
11
Feb
6.8%
72.7%
11
Mar
-12.1%
27.3%
11
Apr
-7.5%
18.2%
11
May
0.1%
50.0%
10
Jun
13.7%
50.0%
10
Jul
1.0%
50.0%
10
Aug
16.6%
80.0%
10
Sep
2.4%
40.0%
10
Oct
11.5%
50.0%
10
Nov
10.0%
60.0%
10
Dec
0.8%
18.2%
11
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
-0.04%
48.0%
494
Tuesday
0.31%
49.3%
546
Wednesday
0.45%
51.8%
542
Thursday
-0.12%
44.8%
533
Friday
0.08%
48.5%
532
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 82.4%
Insider Transactions — Smart Summary
Total insider ownership: 15.9%
12-Month Insider Activity Summary
Total Filings
24
Net Value
-$9.8M
Net Shares Change
8,751,298
% of Float
9.7%
C-Suite Filings
9
Clusters Detected
3
Key Insiders
Name
Title
Net Value
Filings
Activity
RA CAPITAL MANAGEMENT, L.P.
+$54.6M
2
2 buy
Moran Kyle
Chief Financial Officer
-$2.6M
2
1 sell
Tan Aik Na
-$1.2M
1
N/A
HENRY CHRISTIAN O
-$928,530.141
1
N/A
CORRIGAN MARK
-$217,297.883
1
N/A
BOLNO PAUL
President and CEO
-$140,956
1
1 sell
Vargeese Chandra
Chief Technology Officer, Head of Platform Discovery Sciences
-$43,416.6
1
1 sell
Francis Chris
SVP, Corporate Development, Head of Emerging Areas
-$25,326.35
1
1 sell
Transaction Clusters
Period
Filings
Insiders
Net Value
Seniority
2025-08-07 – 2025-08-19
4
3
-$140,203.95
2025-12-10 – 2025-12-10
8
8
-$10.0M
2 C-suite
2026-02-11 – 2026-02-11
4
4
-$257,957.55
4 C-suite
Significant Filings
Date
Insider
Title
Net Value
Price After
2026-03-30
RA CAPITAL MANAGEMENT, L.P.
+$54.6M
Transaction at $6.23, now +1.8%
2026-02-11
Vargeese Chandra
Chief Technology Officer, Head of Platform Discovery Sciences
-$43,416.6
Transaction at $13.45, now -52.9%
2026-02-11
Moran Kyle
Chief Financial Officer
-$48,258.6
Transaction at $13.45, now -52.9%
2026-02-11
Francis Chris
SVP, Corporate Development, Head of Emerging Areas
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Wave Life Sciences Ltd
(WVE) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.